Anpario (LON:ANP) Releases Earnings Results

Anpario (LON:ANP) issued its earnings results on Wednesday. The company reported GBX 22.45 earnings per share for the quarter, Digital Look Earnings reports. Anpario had a return on equity of 16.88% and a net margin of 14.31%.

Anpario Trading Down 2.7%

ANP stock traded down GBX 13.12 on Thursday, reaching GBX 466.88. The company’s stock had a trading volume of 68,672 shares, compared to its average volume of 45,553. The business has a fifty day simple moving average of GBX 531.50 and a two-hundred day simple moving average of GBX 516.75. Anpario has a 12-month low of GBX 391.11 and a 12-month high of GBX 580. The firm has a market cap of £76.04 million, a PE ratio of 12.31 and a beta of 1.08. The company has a debt-to-equity ratio of 0.60, a quick ratio of 5.16 and a current ratio of 4.50.

Analyst Upgrades and Downgrades

A number of analysts have recently weighed in on ANP shares. Canaccord Genuity Group reissued a “buy” rating and set a GBX 570 price objective on shares of Anpario in a research note on Friday, June 26th. Shore Capital Group restated a “house stock” rating on shares of Anpario in a research report on Monday, August 17th. One research analyst has rated the stock with a Buy rating, According to data from MarketBeat, Anpario presently has an average rating of “Buy” and a consensus target price of GBX 570.

About Anpario

Anpario plc, together with its subsidiaries, engages in the production and distribution of natural feed additives for animal health, hygiene, and nutrition. Its health and performance category offers various products that support and maintain animal gut health, such as phytogenic and acid based eubiotics, and omega fatty acids under the Orego-Stim, Optomega, pHorce, Salkil, and Genex brands; feed quality category provides products, such as enzymes, antioxidants, pellet binders, mould inhibitors, and acid based eubiotics under the pHorce, Feedzyme, Salgard, Oxigard, Moldgard, and Mastercube brands.